Three-Year Data Demonstrate Durability of Shape-Changing OmniVu IOL
Overview
The investigational OmniVu Lens System shows sustained refractive stability and a continuous range of vision through 36 months post-implantation. Visual acuity outcomes remain excellent with minimal safety concerns, supporting the potential of shape-changing, modular IOL designs in premium cataract surgery.
Background
Premium intraocular lenses (IOLs) aim to restore a broad range of vision following cataract surgery, addressing presbyopia and refractive errors. Traditional multifocal and accommodating IOLs often face challenges such as dysphotopsia, contrast sensitivity trade-offs, and stability of lens position. The OmniVu Lens System employs a novel two-part modular design with a fluid-filled, shape-changing base to mimic natural accommodation and a front optic for refractive correction. This approach seeks to improve refractive stability and reduce posterior capsule opacification.
Data Highlights
| Parameter | Value at 36 Months |
|---|---|
| Mean manifest refraction spherical equivalent | Within ±0.50 D |
| Mean binocular uncorrected distance visual acuity | -0.11 logMAR (~20/16) |
| Best-corrected distance visual acuity | -0.17 logMAR (~20/12) |
| Mean binocular uncorrected intermediate visual acuity | -0.05 logMAR (20/20) |
| Mean binocular uncorrected near visual acuity | 0.06 logMAR (~20/25) |
| Defocus range with 20/32 or better vision | ~5.0 D continuous defocus |
| YAG capsulotomy rate | 1 event across all eyes and visits |
| Lens exchanges | 0 |
| Refractive enhancements | 0 |
Key Findings
- Mean manifest refraction spherical equivalent remained stable within ±0.50 D over 36 months.
- Excellent visual acuity outcomes with mean binocular uncorrected distance acuity around 20/16 and best-corrected distance acuity approximately 20/12.
- Continuous range of vision demonstrated by 20/32 or better visual acuity across ~5.0 D of defocus, covering distance through near vision.
- Minimal safety concerns: only one YAG capsulotomy reported, with no lens exchanges or refractive enhancements required.
- Early contrast sensitivity comparable to monofocal IOL benchmarks under mesopic conditions, indicating favorable visual quality.
- Modular, fluid-filled design supports stable effective lens position and may reduce posterior capsule opacification.
Clinical Implications
The OmniVu Lens System's sustained refractive stability and broad continuous range of vision suggest it may offer a promising alternative to existing premium IOLs, particularly for patients seeking presbyopia correction with minimal visual disturbances. Its modular, shape-changing design could enhance lens position stability and reduce complications such as posterior capsule opacification, potentially improving long-term outcomes. Surgeons should monitor ongoing clinical trials to evaluate its future role in cataract surgery.
Conclusion
The three-year first-in-human data validate the durability and functional benefits of the OmniVu shape-changing IOL, highlighting its potential to advance premium cataract surgery. Continued clinical evaluation will clarify its place in the evolving presbyopia-correcting IOL landscape.
Related Resources & Content
- Atia Vision/BusinessWire/2026 -- Three-Year Data for OmniVu Lens System Presented at ASCRS
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
